Mishra Pratap Kumar, Mishra Ipsita, Choudhury Arun Kumar, Baliarsinha Anoj Kumar, Mangaraj Swayam Sidha, Jena Sweekruti, Mohanty Binoy Kumar
Department of Endocrinology, Capital Hospital, Bhubaneshwar, Odisha, India.
Department of Endocrinology, SCB Medical College and Hospital, Cuttack, Odisha, India.
Indian J Endocrinol Metab. 2022 Mar-Apr;26(2):160-166. doi: 10.4103/ijem.ijem_448_21. Epub 2022 Jun 6.
Constitutional delay in growth and puberty (CDGP) is a normal physiological variant of delayed puberty in both sexes and is the most common cause of delayed puberty. Idiopathic hypogonadotropic hypogonadism (IHH) is due to deficiency in or insensitivity to gonadotropin-releasing hormone (GnRH) with normal structure and function of the anterior pituitary after exclusion of secondary causes of hypogonadotropic hypogonadism. To differentiate CDGP from IHH is crucial because it not only helps in decision making in management but also lessen anxiety of the parents.
In this study we aimed to find out the accuracy of hormonal tests used individually as well as in various combinations to distinguish cases of IHH from CDGP.
A cohort of 34 boys with delayed puberty were recruited in this study. Detailed history, clinical examination, hormonal analysis including basal serum testosterone, inhibin-B, LH, FSH as well as GnRH analogue stimulated gonadotrophins and testosterone along with hCG stimulated testosterone was done. At 6 monthly follow-up, detailed clinical examination was repeated and the cohort was followed until 2 years.
Out of the 29 boys taken for final analysis, CDGP was diagnosed in 23 boys and IHH in 6 boys. Basal LH, basal inhibin-B, 3 hours post leuprolide LH and 72 hours post hCG testosterone were significantly higher in CDGP than IHH. However, no statistically significant difference was observed between basal FSH, basal testosterone and 3 hours post leuprolide FSH between these two groups. When basal LH (cut-off <0.565 IU/L) and basal inhibin-B (cut-off <105 pg/ml) were taken together the sensitivity and specificity were increased to 100% as was for the combination of basal LH (cutoff <0.565 IU/L) and 3 hours post leuprolide LH (cutoff <6.16 IU/L) for diagnosis of IHH. Both combinations have PPV of 100% and NPV of 100%. A combination of 3 hours post leuprolide LH with 72 hours post hCG testosterone also has good sensitivity (100%), specificity (96%), PPV (90%) and NPV (100%).
Differentiating IHH from CDGP is a challenging task due to considerable overlap in their clinical as well as hormonal profiles. Therefore we suggest that a combination of basal LH and basal inhibin-B may be considered as a useful screening tool to differentiate IHH from CDGP rather than the cumbersome and invasive stimulation tests.
体质性生长和青春期延迟(CDGP)是男女青春期延迟的一种正常生理变异,是青春期延迟最常见的原因。特发性低促性腺激素性性腺功能减退(IHH)是由于促性腺激素释放激素(GnRH)缺乏或不敏感,排除继发性低促性腺激素性性腺功能减退的原因后,垂体前叶结构和功能正常。区分CDGP和IHH至关重要,因为这不仅有助于管理决策,还能减轻家长的焦虑。
在本研究中,我们旨在找出单独使用以及各种组合使用的激素检测方法区分IHH和CDGP病例的准确性。
本研究招募了34名青春期延迟的男孩。进行了详细的病史询问、临床检查、激素分析,包括基础血清睾酮、抑制素B、促黄体生成素(LH)、促卵泡生成素(FSH),以及GnRH类似物刺激后的促性腺激素和睾酮,还有人绒毛膜促性腺激素(hCG)刺激后的睾酮。每6个月进行一次随访,重复详细的临床检查,并对该队列随访至2年。
在纳入最终分析的29名男孩中,23名男孩被诊断为CDGP,6名男孩被诊断为IHH。CDGP组的基础LH、基础抑制素B、亮丙瑞林注射后3小时的LH和hCG注射后72小时的睾酮显著高于IHH组。然而,两组之间的基础FSH、基础睾酮和亮丙瑞林注射后3小时的FSH无统计学显著差异。当基础LH(临界值<0.565 IU/L)和基础抑制素B(临界值<105 pg/ml)联合使用时,诊断IHH的敏感性和特异性均提高到100%,基础LH(临界值<0.565 IU/L)和亮丙瑞林注射后3小时的LH(临界值<6.16 IU/L)联合使用时也是如此。两种组合的阳性预测值(PPV)均为100%,阴性预测值(NPV)均为100%。亮丙瑞林注射后3小时的LH与hCG注射后72小时的睾酮联合使用也具有良好的敏感性(100%)、特异性(96%)、PPV(90%)和NPV(100%)。
由于IHH和CDGP在临床和激素特征上有相当大的重叠,区分两者是一项具有挑战性的任务。因此,我们建议基础LH和基础抑制素B的联合使用可被视为区分IHH和CDGP的有用筛查工具,而非繁琐且有创的刺激试验。